Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Planning your retirement portfolio at 40? Discover essential assets to include for a balanced and secure financial future.
20,742 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Investors are turning to AI prompting to translate complex data into sharper bets as markets rise in early 2026. Expe...
Dell Technologies beat Q4 expectations and raised FY27 guidance, underscoring the surge in AI-optimized servers. As i...
In 2025, holdings' 2025 review: from fintech disruptor to banking powerhouse marks a turning point from rapid scale t...
Kontoor Brands posted Q4 2025 results with revenue above $1B and a solid earnings beat, driven by a key acquisition. ...
USA Rare Earth's stock dropped 15.7% in February as broad markets wobbled, but March brought signs of life. This guid...
Stratasys beat on both earnings and revenue, yet stratasys stock just crashed as investors weighed guidance and marke...
Friday brought a sharp move for algonquin power utilities stock as investors digested a guidance miss for 2027. This ...
Even the wealthiest households lean on debt to fund luxury real estate, a strategy that preserves liquidity for other...
Hycroft Mining and Silvercorp Metals jumped in today's session as gold and silver miners rally on heightened geopolit...
Minnesota’s business elite issued a restrained message on immigration enforcement that drew sharp critique and raised...
Geopolitical risk surges after reports that Iran’s supreme leader warned of expanding fronts in the Middle East. Mark...